GENEVA, June 26 -- LIANGZHU LABORATORY filed a patent application (CN2025/137645) for “HM4DI MUTANT AND USE THEREOF IN PREPARATION OF DRUG FOR TREATING PARKINSON'S DISEASE”. With publication no. WO/2026/118958, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/705
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....